US 12414953
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted A61KA61K31/519A61P
Quick answer
US patent 12414953 (Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)) held by Prelude Therapeutics, Incorporated expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prelude Therapeutics, Incorporated
- Grant date
- Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 70
- CPC classes
- A61K, A61K31/519, A61P, A61P35/00